-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$26.402.01% Upside
TG Therapeutics, Inc. Frequently Asked Questions
-
What analysts cover TG Therapeutics, Inc.?
TG Therapeutics, Inc. has been rated by research analysts at Goldman Sachs, H.C. Wainwright, Cantor Fitzgerald, Evercore ISI, Telsey Advisory in the past 90 days.